Fathi, Heba M.
Fahmy, Ahmed M.
Shaker, Michael Adel
Kamel, Alshaimaa Abdel Fattah https://orcid.org/0000-0002-8102-210X
Article History
Received: 18 June 2025
Accepted: 29 September 2025
First Online: 29 November 2025
Declarations
:
: The present study was a prospective, randomized, single- blind, clinical trial. The protocol was ethically approved by Zagazig University’s Institutional Review Board (IRB#9577/19-9-2022). The clinicaltrials.gov number was (NCT05672784, 5-11-2022). . The first patient was enrolled on 15th November 2022.Written informed consent was obtained from all participants after they understood the concept of this research. The study was performed in accordance with the regulations and guidelines of Helsinki Declarations.
: Not Applicable.
: The authors declare no competing interests.